Investigations on the Usefulness of CEACAMs as Potential Imaging Targets for Molecular Imaging Purposes
Name
Heine-2011-Investigations on th.pdf
Size
1.18 MB
Format
Adobe PDF
Checksum (MD5)
25c879e5845634f691a6b50dd7c455aa
Author(s)
Heine, Markus
Nollau, Peter
Masslo, Christoph
Nielsen, Peter
Freund, Barbara
Reimer, Rudolph
Hohenberg, Heinrich
Peldschus, Kersten
Ittrich, Harald
Schumacher, Udo
Date Issued
December 2011
Journal
PLoS ONE
Publisher
Public Library of Science
Citation
Heine, Markus et al. “Investigations on the Usefulness of CEACAMs as Potential Imaging Targets for Molecular Imaging Purposes.” Ed. C. Andrew Boswell. PLoS ONE 6.12 (2011): e28030. Web. 8 Feb. 2012.
Version
Final published version
Abstract
Members of the carcinoembryonic antigen cell adhesion molecules (CEACAMs) family are the prototype of tumour markers. Classically they are used as serum markers, however, CEACAMs could serve as targets for molecular imaging as well.
In order to test the anti CEACAM monoclonal antibody T84.1 for imaging purposes, CEACAM expression was analysed using this antibody. Twelve human cancer cell lines from different entities were screened for their CEACAM expression using qPCR, Western Blot and FACS analysis. In addition, CEACAM expression was analyzed in primary tumour xenografts of these cells. Nine of 12 tumour cell lines expressed CEACAM mRNA and protein when grown in vitro. Pancreatic and colon cancer cell lines showed the highest expression levels with good correlation of mRNA and protein level. However, when grown in vivo, the CEACAM expression was generally downregulated except for the melanoma cell lines. As the CEACAM expression showed pronounced expression in FemX-1 primary tumours, this model system was used for further experiments. As the accessibility of the antibody after i.v. application is critical for its use in molecular imaging, the binding of the T84.1 monoclonal antibody was assessed after i.v. injection into SCID mice harbouring a FemX-1 primary tumour. When applied i.v., the CEACAM specific T84.1 antibody bound to tumour cells in the vicinity of blood vessels. This binding pattern was particularly pronounced in the periphery of the tumour xenograft, however, some antibody binding was also observed in the central areas of the tumour around blood vessels. Still, a general penetration of the tumour by i.v. application of the anti CEACAM antibody could not be achieved despite homogenous CEACAM expression of all melanoma cells when analysed in tissue sections. This lack of penetration is probably due to the increased interstitial fluid pressure in tumours caused by the absence of functional lymphatic vessels.
MIT Department
Massachusetts Institute of Technology. Department of Chemistry
Massachusetts Institute of Technology. Department of Chemistry
Terms of Use
Creative Commons Attribution
Persistent DSpace Link
DOI of Published Version
https://doi.org/10.1371/journal.pone.0028030
